 Dividend.com | Bristol sales and earnings fall as generics take a toll Reuters * Q2 profit ex-items 48 cents/share, matches Street view * Q2 sales $4.44 bln vs Street view $4.45 bln * Plavix sales fall 60 pct, Avapro tumbles 53 pct * Shares up slightly in early trading By Ransdell Pierson July 25 (Reuters) - Bristol-Myers Squibb ... Patent Expirations Hurt Bristol-Myers's Results Bristol-Myers Second-Quarter Profit Falls on Plavix Sales Drop Generic rivals choke Bristol-Myers 2Q results |
Wednesday, July 25, 2012
Bristol sales and earnings fall as generics take a toll - Reuters
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment